| 2024 |
Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study
10.1136/bmj-2023-076268
Authors: P. Mok, M. Carr, B. Guthrie, D. Morales, A. Sheikh, R. Elliott, E. Camacho, T. Van Staa, A. Avery, D. Ashcroft |
| 2024 |
Enhancing recruitment of individuals living with frailty, multimorbidity and cognitive impairment to Parkinson's research: experiences from the PRIME-UK cross-sectional study
10.1093/ageing/afae108
Authors: E. Tenison, M. Smith, D. Pendry-Brazier, A. Cullen, F. Lithander, Y. Ben-Shlomo, E. Henderson |
| 2024 |
Prevalence, incidence and healthcare burden of eosinophilic granulomatosis with polyangiitis in the UK
10.1183/23120541.00430-2023
Authors: J. Hwee, L. Harper, Q. Fu, K. Nirantharakumar, G. Mu, R. Jakes |
| 2024 |
Potential interactions between medications for rate control and direct oral anticoagulants: population-based cohort and case-crossover study
10.1016/j.hrthm.2024.06.033
Authors: A . Y. Wong, C. Warren-Gash, K. Bhaskaran, C. Leyrat, A. Banerjee, L. Smeeth, I. Douglas |
| 2024 |
Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach
10.1007/s00125-024-06190-9
Authors: L. Güdemann, K. Young, N. Thomas, R. Hopkins, R. Challen, A. Jones, A. Hattersley, E. Pearson, B. Shields, J. Bowden, J. Dennis, A. McGovern |
| 2024 |
Could primary care records be used to identify women at risk of perinatal anxiety? A mixed-methods study
10.3399/bjgp24X737673
Authors: T. Fisher, C. Archer, J. Bailey, J. Evans, D. Kessler, T. Kingstone, I. Petersen, J. Proctor, N. Shivji, A. Spruce, V. Silverwood, H. Smith, K. Turner, P. Wu, D. Yu, C. Chew-Graham |
| 2024 |
Impact of pregnancy vaccine uptake and socio-demographic determinants on subsequent childhood Measles, Mumps and Rubella vaccine uptake: A UK birth cohort study
10.1016/j.vaccine.2023.11.063
Authors: H. Skirrow, K. Foley, H. Bedford, C. Lewis, E. Whittaker, C. Costelloe, S. Saxena |
| 2024 |
Risk of abnormal uterine bleeding associated with high-affinity compared with low-affinity serotonin and norepinephrine reuptake inhibitors
10.1016/j.jad.2024.01.163
Authors: J. Engler, C. Filliter, F. Montastruc, H. Abenhaim, S. Rej, C. Renoux |
| 2024 |
Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions
10.1093/eurjpc/zwae174
Authors: LIFE-CVD2 Group |
| 2024 |
Outcomes in patients treated with loop diuretics without a diagnosis of heart failure: a retrospective cohort study
10.1136/heartjnl-2023-323577
Authors: J. Cuthbert, I. Soyiri, S. Lomax, J. Turgoose, A. Fuat, J. Cohen, A. Clark |
| 2024 |
The Impact of the COVID-19 Pandemic on Incidence and Short-Term Survival for Common Solid Tumours in the United Kingdom: A Cohort Analysis
10.2147/clep.s463160
Authors: N. Barclay, T. Burkard, E. Burn, A. Delmestri, Miquel Dominguez, A. Golozar, C. Guarner-Argente, F. Avilés-Jurado, W . Y. Man, Roselló Serrano, A. Rosen, E. Tan, I. Tietzova, Prieto Alhambra, D. Newby |
| 2024 |
Autoimmune conditions and gastric cancer risk in a population-based study in the United Kingdom
10.1038/s41416-024-02714-7
Authors: J. Murphy, S. Gadalla, L. Anderson, C. Rabkin, C. Cardwell, M. Song, M. Camargo |
| 2024 |
Greenhouse gas emissions associated with suboptimal asthma care in the UK: the SABINA healthCARe-Based envirONmental cost of treatment (CARBON) study
10.1136/thorax-2023-220259
Authors: A. Wilkinson, E. Maslova, C. Janson, V. Radhakrishnan, J. Quint, N. Budgen, T. Tran, Y. Xu, A. Menzies-Gow, J. Bell |
| 2024 |
Identification of misclassified pregnancy episodes in women of childbearing potential exposed to drugs with known teratogenic potential in the CPRD GOLD Pregnancy Register
10.1002/pds.5761
Authors: C. Lee, S. Rizzi, A. Bierrenbach, L. Antunes, N. Nissinen, O. Rocha, J. Campbell, C. Minassian, S. Hodgson, A. Broe |
| 2024 |
Perceptions on artificial intelligence-based decision-making for coexisting multiple long-term health conditions: protocol for a qualitative study with patients and healthcare professionals
10.1136/bmjopen-2023-077156
Authors: N. Gunathilaka, T. Gooden, J. Cooper, S. Flanagan, T. Marshall, S. Haroon, A. D'Elia, F. Crowe, T. Jackson, K. Nirantharakumar, S. Greenfield |
| 2024 |
Identifying prior signals of bipolar disorder using primary care electronic health records: a nested case-control study
10.3399/bjgp.2022.0286
Authors: C. Morgan, D. Ashcroft, C. Chew-Graham, M. Sperrin, R. Webb, A. Francis, J. Scott, A. Yung |
| 2024 |
Prescribing trends of proton pump inhibitors and histamine blockers among children in the United Kingdom (1998-2019): A population-based assessment
10.1002/pds.5752
Authors: R. Masarwa, P. Reynier, C. Lefebvre, R. Platt, J. Delaney, K. Filion |
| 2024 |
Predicting incident heart failure from population-based nationwide electronic health records: protocol for a model development and validation study
10.1136/bmjopen-2023-073455
Authors: Y. Nakao, R. Nadarajah, F. Shuweihdi, K. Nakao, A. Fuat, J. Moore, C. Bates, J. Wu, C. Gale |
| 2024 |
Gout and incidence of 12 cardiovascular diseases: a case-control study including 152 663 individuals with gout and 709 981 matched controls
10.1016/s2665-9913(23)00338-7
Authors: L. Ferguson, G. Molenberghs, G. Verbeke, K. Rahimi, S. Rao, I. McInnes, J. McMurray, N. Sattar, N. Conrad |
| 2024 |
Use of drugs for hyperlipidaemia and diabetes and risk of primary and secondary brain tumours: nested case-control studies using the UK Clinical Practice Research Datalink (CPRD)
10.1136/bmjopen-2023-072026
Authors: J. Robinson, R. Martin, M. Ozawa, M. Elwenspoek, M. Redaniel, K. Kurian, Y. Ben-Shlomo |
| 2024 |
Population-based study of alcohol-related liver disease in England 2001-2018: Influence of socioeconomic position
10.14309/ajg.0000000000002677
Authors: G. Askgaard, P. Jepsen, M. Jensen, A. Kann, J. Morling, F. Kraglund, T. Card, C. Crooks, J. West |
| 2024 |
Initiation patterns of anticoagulants for atrial fibrillation among older UK adults with and without chronic kidney disease, 2010-2020
10.1136/openhrt-2023-002515
Authors: J. Liaw, D. Liaw, C. Dave |
| 2024 |
Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study
10.1093/ehjcvp/pvae022
Authors: T. Eroglu, R. Coronel, P. Souverein |
| 2024 |
Real-world evidence of epidemiology, patient characteristics, and mortality in people with drug-resistant epilepsy in the United Kingdom, 2011-2021
10.1007/s00415-023-12165-4
Authors: R. Shankar, X. Marston, V. Danielson, Do Rego, R. Lasagne, O. Williams, L. Groves |
| 2024 |
The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia
10.1016/s2213-2600(23)00414-9
Authors: M. Català, N. Mercadé-Besora, R. Kolde, N. Trinh, E. Roel, E. Burn, T. Rathod-Mistry, K. Kostka, W . Y. Man, A. Delmestri, H. Nordeng, A. Uusküla, T. Duarte-Salles, D. Prieto-Alhambra, A. Jödicke |
| 2024 |
Treatment pathways, economic burden and clinical outcomes in new users of inhaled corticosteroid/long-acting B(2)-agonist dual therapy with chronic obstructive pulmonary disease in a primary care setting in England: a retrospective cohort study
10.1136/bmjopen-2023-072361
Authors: A. Czira, V. Banks, G. Requena, R. Wood, T. Tritton, R. Wild, C. Compton, A. Ismaila |
| 2024 |
Smoking is a Risk Factor for Autoimmune Hepatitis: An English Registry-Based Case-Control Study
10.2147/clep.s439219
Authors: L. Grønbæk, H. Omeife, L. Ban, C. Crooks, T. Card, P. Jepsen, J. West |
| 2024 |
Uptake and safety of pneumococcal vaccination in adults with immune mediated inflammatory diseases: a UK wide observational study
10.1093/rheumatology/keae160
Authors: G. Nakafero, M. Grainge, T. Card, C. Mallen, J. Van-Tam, A. Abhishek |
| 2024 |
Oral prednisolone and warfarin and risk of oesophageal cancer: A case-control study
10.1016/j.canep.2024.102552
Authors: C. Cardwell, R. McDowell, C. Hughes, J. Busby, P. Murchie |
| 2024 |
Implementation and external validation of the Cambridge Multimorbidity Score in the UK Biobank cohort
10.1186/s12874-024-02175-9
Authors: H. Harrison, S. Ip, C. Renzi, Y. Li, M. Barclay, J. Usher-Smith, G. Lyratzopoulos, A. Wood, A. Antoniou |
| 2024 |
Association between patient ethnicity and prostate cancer diagnosis following a prostate-specific antigen test: a cohort study of 730,000 men in primary care in the UK
10.1186/s12916-024-03283-5
Authors: L. Down, M. Barlow, S. Bailey, L. Mounce, S. Merriel, J. Watson, T. Martins |
| 2024 |
Sodium-glucose cotransporter-2 inhibitors and the risk of lung cancer among patients with type 2 diabetes
10.1111/bcp.16039
Authors: S. Shapiro, H. Yin, O. H. Y. Yu, L. Azoulay |
| 2024 |
How common are side effects of treatment to prevent gout flares when starting allopurinol?
10.1136/bmj.q514
Authors: H. Saul, B. Deeney, L. Swaithes, E. Roddy |
| 2024 |
Clostridioides difficile infections, recurrences, and clinical outcomes in real-world settings from 2015 to 2019: The RECUR England study
10.1016/j.ijid.2024.01.002
Authors: S. Ghosh, A. Antunes, H. Rinta-Kokko, E. Chaparova, S. Lay-Flurrie, A. Tricotel, F. Andersson |
| 2024 |
Eligibility of patients with chronic obstructive pulmonary disease for inclusion in randomised control trials investigating triple therapy: a study using routinely collected data
10.1186/s12931-024-02672-x
Authors: H. Whittaker, A. Torkpour, J. Quint |
| 2024 |
Burden of Disease and Treatment Patterns Amongst Patients With Vitiligo: Findings From a National, Longitudinal Retrospective Study in the United Kingdom
10.1093/bjd/ljae133
Authors: V. Eleftheriadou, C. Delattre, S. Chetty-Mhlanga, C. Lee, L. Girardat-Rotar, I. Khan, A. Mathew, A. Thompson |
| 2024 |
5-year mental health outcomes for children and adolescents presenting with psychiatric symptoms to general practitioners in England: a retrospective cohort study
10.1016/s2215-0366(24)00038-5
Authors: M. Senior, M. Pierce, V. Taxiarchi, S. Garg, D. Edge, T. Newlove-Delgado, S. Neufeld, K. Abel |
| 2024 |
Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation
10.1136/rmdopen-2023-003980
Authors: A. Abhishek, M. Grainge, T. Card, H. Williams, M. Taal, G. Aithal, C. Fox, C. Mallen, M. Stevenson, G. Nakafero, R. Riley |
| 2024 |
Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study
10.1136/bmj-2023-078242
Authors: N. Simms-Williams, N. Treves, H. Yin, S. Lu, O. Yu, R. Pradhan, C. Renoux, S. Suissa, L. Azoulay |
| 2024 |
Health Care Resource Utilization and Costs Associated With COVID-19 Among Pediatrics Managed in the Community or Hospital Setting in England: A Population-based Cohort Study
10.1097/inf.0000000000004213
Authors: J. Yang, K. Andersen, K. Rai, T. Tritton, T. Mugwagwa, C. Tsang, M. Reimbaeva, L. McGrath, P. Payne, B. Backhouse, D. Mendes, R. Butfield, R. Wood, J. Nguyen |
| 2024 |
The long-term impact of vaginal surgical mesh devices on pain clinic and psychological service referrals, anti-inflammatory testing and pelvic scans in UK primary care: A cohort study with the Clinical Practice Research Datalink
10.1111/1471-0528.17828
Authors: E. McFadden, C. Heneghan |
| 2024 |
Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in England from 2008 to 2018: a cohort study
10.1136/thorax-2023-220887
Authors: R. Gupta, A. Morgan, P. George, J. Quint |
| 2024 |
Risk of fractures in half a million survivors of 20 cancers: a population-based matched cohort study using linked English electronic health records
10.1016/s2666-7568(23)00285-4
Authors: E. Buzasi, H. Carreira, G. Funston, K. Mansfield, H. Forbes, H. Strongman, K. Bhaskaran |
| 2024 |
Risk factor associations for severe COVID-19, influenza and pneumonia in people with diabetes to inform future pandemic preparations: UK population-based cohort study
10.1136/bmjopen-2023-078135
Authors: R. Hopkins, K. Young, N. Thomas, J. Godwin, D. Raja, B. Mateen, R. Challen, S. Vollmer, B. Shields, A. McGovern, J. Dennis |
| 2024 |
Prevalence, incidence, mortality, and healthcare resource use for generalised pustular psoriasis, palmoplantar pustulosis, and plaque psoriasis in England: a population-based cohort study
10.1093/bjd/ljae217
Authors: M. Frysz, S. Patel, M. O. Y. Li, C. Griffiths, R. Warren, D. Ashcroft |
| 2024 |
The effectiveness of revaccination with pneumococcal polysaccharide vaccine for preventing pneumococcal disease in older adults in England: A population-based cohort study
10.1016/j.vaccine.2024.05.050
Authors: K. Doherty, L. Bonnett, S. Agbla, N. Beveridge, V. Decraene, K. Fleming, D. Hungerford, N. French |
| 2024 |
Risk of bleeding amongst warfarin and direct oral anticoagulant users prescribed immediate antibiotics for respiratory tract infection: Cohort study
10.1002/pds.5794
Authors: H. Ahmed, N. Reeve, D. Farewell, F. Hamilton, M. Ponsford, J. Hippisley-Cox, S. Noble |
| 2024 |
Systemic Fluoroquinolone Use and Risk of Uveitis or Retinal Detachment
10.1001/jamaophthalmol.2024.1712
Authors: J. Brown, K. Wing, S. Evans, C. Leyrat, K. Mansfield, L. Smeeth, A. Wong, D. Yorston, N. Galwey, I. Douglas |
| 2024 |
A Harmonised Approach to Curating Research-Ready Datasets for Asthma, Chronic Obstructive Pulmonary Disease (COPD) and Interstitial Lung Disease (ILD) in England, Wales and Scotland Using CPRD, SAIL Databank and DataLoch
10.2147/clep.s437937
Authors: S. Hatam, S. Scully, S. Cook, H. Evans, A. Hume, C. Kallis, I. Farr, C. Orton, A. Sheikh, J. Quint |
| 2024 |
Fluoroquinolones and the risk of severe hypoglycaemia among sulphonylurea users: Population-based cohort study
10.1111/dom.15627
Authors: J. Dimakos, Y. Cui, R. Platt, C. Renoux, K. Filion, A. Douros |
